[1]杨启梅,李 安,赵 博,等.奥美拉唑在分泌性中耳炎合并咽喉反流患者中的治疗价值[J].陕西医学杂志,2024,(5):680-683.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.023]
　YANG Qimei,LI An,ZHAO Bo,et al.Therapeutic value of omeprazole in patients with secretory otitis media combined with laryngopharyngeal reflux[J].,2024,(5):680-683.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.023]
点击复制

奥美拉唑在分泌性中耳炎合并咽喉反流患者中的治疗价值
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年5期
页码:
680-683
栏目:
药物与临床
出版日期:
2024-05-05

文章信息/Info

Title:
Therapeutic value of omeprazole in patients with secretory otitis media combined with laryngopharyngeal reflux
作者:
杨启梅; 李 安; 赵 博; 张 文; 刘 晖
(陕西省人民医院耳鼻咽喉头颈外科,陕西 西安 710068)
Author(s):
YANG Qimei; LI An; ZHAO Bo; ZHANG Wen; LIU Hui
(Department of Otolaryngology Head and Neck Surgery,Shaanxi Provincial People's Hospital,Xi'an 710068,China)
关键词:
分泌性中耳炎;  咽喉反流;  抗反流干预;  奥美拉唑;  气骨导差;  七项咽鼓管功能障碍症状评分量表
Keywords:
Secretory otitis media;  Laryngopharyngeal reflux;  Anti-reflux intervention;  Omeprazole;  Air bone gap;  Seven-item eustachian tube dysfunction questionnaire
分类号:
R 764.21
DOI:
DOI:10.3969/j.issn.1000-7377.2024.05.023
文献标志码:
A
摘要:
目的:探讨奥美拉唑在分泌性中耳炎(SOM)合并咽喉反流(LPR)患者中的治疗价值。方法:选取单侧或双侧SOM合并LPR患者82例,根据治疗方案不同将患者分为治疗组(35例)和对照组(47例)。所有患者均给予鼓膜穿刺术、配合使用鼻部激素、口服黏液促排剂和抗组胺药物1个月。治疗组同时给予患者抗反流宣教及足疗程奥美拉唑抗反流干预。随访3个月,比较两组患者治疗前后气骨导差、七项咽鼓管功能障碍症状评分量表(ETDQ-7)评分及临床疗效。结果:两组治疗后第1～3个月气骨导差较治疗前降低(均P<0.05)。治疗组治疗后第1～3个月气骨导差低于对照组(均P<0.05)。两组患者治疗后第1～3个月ETDQ-7评分较治疗前降低(均P<0.05)。治疗组治疗后第1～3个月ETDQ-7评分较对照组降低(均P<0.05)。治疗后第2、3个月,治疗组总有效率高于对照组(均P<0.05)。结论:对于SOM合并LPR患者,奥美拉唑能改善咽鼓管功能,提高听力水平及SOM治疗效果。
Abstract:
Objective:To investigate the therapeutic value of omeprazole in patients with secretory otitis media(SOM)combined with laryngopharyngeal reflux(LPR).Methods: A total of 82 patients with unilateral or bilateral SOM combined with LPR were selected and divided into treatment group(35 cases)and control group(47 cases)according to different treatment regiments.All patients were given tympanocentesis combined with nasal hormones,oral mucostimulants and antihistamines for one month.Patients in the treatment group were also given anti-reflux education and an adequate course of omeprazole anti-reflux intervention.The patients were followed up for 3 months,and the air bone gap,seven-item eustachian tube dysfunction questionnaire(ETDQ-7)score and clinical efficacy of the two groups were compared before and after treatment.Results: The air bone gap in 1 to 3 months after treatment was lower than that before treatment(all P<0.05).The air bone gap in the treatment group was lower than that in the control group at 1 to 3 months after treatment(all P<0.05).The ETDQ-7 scores in the first 1 to 3 months after treatment in both groups were lower than those before treatment(all P<0.05).The ETDQ-7 score of the treatment group was lower than that of the control group at 1 to 3 months after treatment(all P<0.05).At 2 and 3 months after treatment,the total effective rates of the treatment group were higher than that of the control group(all P<0.05).Conclusion:For SOM patients with LPR,omeprazole can improve the function of pharyngotympanical tube,improve the hearing level and the therapeutic effect of SOM.

参考文献/References:

[1] 江坚,周雪.从痰饮论治慢性分泌性中耳炎[J].陕西中医,2020,41(10):1458-1460.
[2] 王挺,杨英,王锁欣.和胃降逆法治疗分泌性中耳炎32例[J].陕西中医,2014,35(5):567-568.
[3] MILLS R,HATHORN I.Aetiology and pathology of otitis media with effusion in adult life[J].J Laryngol Otol,2016,130(5):418-424.
[4] LECHIEN J R,HANS S,SIMON F,et al.Association between laryngopharyngeal reflux and media otitis:A systematic review[J].Otol Neurotol,2021,42(7):801-814.
[5] 王瑶君,王岩.色甘萘甲那敏鼻喷雾剂治疗急性非化脓性中耳炎疗效及对患者血清miR-203a和miR-155的影响[J].陕西医学杂志,2020,49(2):220-222.
[6] 李建玲,赵广辉,刘杰.耳内镜下鼓膜置管术与鼓膜穿刺术治疗分泌性中耳炎疗效对比研究[J].陕西医学杂志,2018,47(8):1023-1025,1035.
[7] 汤智平,陈庆利,邱若庆,等.成年人咽喉反流与分泌性中耳炎的相关性研究[J].听力学及言语疾病杂志,2018,26(2):159-161.
[8] KARYANTA M,SATROWIYOTO S,WULANDARI D P.Prevalence ratio of otitis media with effusion in laryngopharyngeal reflux[J].Int J Otolaryngol,2019,2019:7460891.
[9] LECHIEN J R,MANIACI A,GENGLER I M,et al.Laryngopharyngeal reflux in otitis media with effusion[J].Am J Otolaryngol,2023,45(2):104152.
[10] 彭雨婷,徐丹,刘雪莱,等.重庆地区耳鼻咽喉头颈外科门诊咽喉反流性疾病的流行病学调查[J].临床耳鼻咽喉头颈外科杂志,2021,35(4):351-354,359.
[11] 张承宁,胡德馨,李婷婷,等.贵州省南部地区20岁及以上农村居民咽喉反流性疾病的调查[J].现代预防医学,2022,49(6):1066-1069.
[12] 张晓娜,李兰.咽喉反流与学龄前儿童分泌性中耳炎的相关性分析[J].中国耳鼻咽喉头颈外科,2022,29(12):801-803.
[13] 李进让,肖水芳,李湘平,等.咽喉反流性疾病诊断与治疗专家共识(2015年)[J].中华耳鼻咽喉头颈外科杂志,2016,51(5):324-326.
[14] SCHILDER A G,BHUTTA M F,BUTLER C C,et al.Eustachian tube dysfunction:Consensus statement on definition,types,clinical presentation and diagnosis[J].Clin Otolaryngol,2015,40(5):407-411.
[15] 杨启梅,韩想利,杨晓蓉,等.内镜引导下激素经导管法咽鼓管吹张治疗分泌性中耳炎的短期疗效评估[J].中国耳鼻咽喉头颈外科,2022,29(2):94-96,103.
[16] LECHIEN J R,HANS S,SIMON F,et al.Association between laryngopharyngeal reflux and media otitis:A systematic review[J].Otol Neurotol,2021,42(7):e801-e814.
[17] ZHEN Z,ZHAO T,WANG Q,et al.Laryngopharyngeal reflux as a potential cause of eustachian tube dysfunction in patients with otitis media with effusion[J].Front Neurol,2022,13:1024743.
[18] ABDEL-AZIZ M M,ABDEL-FATTAH A M,ABDALLA A F.Clinical evaluation of pepsin for laryngopharyngeal reflflux in children with otitis media with effffusion[J].Int J Pediatr Otorhinolaryngol,2013,77(10):1765-1770.
[19] REILLY R C,HE Z,BLOEDON E,et al.The role of extraesophageal reflux in otitis media in infants and children[J].Laryngoscope,2008,118:1-9.
[20] LUO H N,YANG Q M,SHENG Y,et al.Role of pepsin and pepsinogen:Linking laryngopharyngeal reflux with otitis media with effusion in children[J].Laryngoscope,2014,124(7):294-300.
[21] GORECKA-TUTEJA A,JASTRZEBSKA I,SKLADZIEN J,et al.Laryngopharyngeal reflux in children with chronic otitis media with effusion[J].J Neurogastroenterol Motil,2016,22(3):452-458.
[22] 雷蕾,赵宇,郑艳,等.成人咽喉反流与慢性分泌性中耳炎的相关性研究[J].临床耳鼻咽喉头颈外科杂志,2018,32(15):1167-1170.
[23] SONE M,KATAYAMA N,KATO T,et al.Prevalence of laryngopharyngeal reflux symptoms:Comparison between health checkup examinees and patients with otitis media[J].Otolaryngol Head Neck Surg,2012,146(4):562-566.
[24] POELMANS J,TACK J,FEENSTRA L.Prospective study on the incidence of chronic era complaints related to gastroesophageal reflux and on the outcome of antireflux therapy[J].Ann Otol Rhinol Laryngol,2002,111(10):933-938.
[25] 汤智平,吴志明,李文波,等.咽喉反流干预对治疗反流相关的难治性分泌性中耳炎的疗效[J].广东医学,2022,43(4):482-486.
[26] SONG J J,KOWN S K,KIM E J,et al.Mucosal expression of ENaC and AQP in experimental otitis media induced by eustachian tube obstruction[J].Int J Pediatr Otorhinolaryngol,2009,73(11):1589-1593.
[27] BRUNWORTH J D,MAHBOUBI H,GARG R,et al.Nasopharyngeal acid reflux and eustachian tube dysfunction in adults[J].Ann Otol Rhinol Laryngol,2014,123(6):415-419.

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划项目(2023-YBSF-081); 陕西省创新能力支撑计划项目(2022TD-51); 陕西省人民医院科技发展孵化基金资助项目(2022YJY-20); 陕西省人民医院科技人才支持计划项目(2021JY-16)
更新日期/Last Update: 2024-05-06